Idogen’s treatment is based on dendritic cells, types of white blood cells, that play a central role in the immune system, because they control other immune system cells’ recognition of what belongs in the body (self) and what is foreign (non-self). When we are exposed to potentially harmful bacteria or viruses, the dendritic cells trigger our immune response. At the same time, they ensure that the immune system does not attack our own body. The dendritic cells that prevent the immune system from attacking the body’s own healthy cells are called tolerogenic. The aim of Idogen’s technology is to develop tolerogenic dendritic cells that are programmed for defined molecules or antigens.